JENNIFER POUND: Open Payments
NPI 1881021285 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,584 in 88 payments from 22 companies in 2025. Trend: 2023 $1,754 · 2024 $1,862 · 2025 $1,584
Food & beverage: $1,584
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $236 |
| Lilly USA, LLC | 13 | $233 |
| PFIZER INC. | 15 | $222 |
| ABBVIE INC. | 14 | $219 |
| Amgen Inc. | 7 | $115 |
| Novo Nordisk Inc | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Lundbeck LLC | 3 | $68 |
| Astellas Pharma US Inc | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
Products named: MOUNJARO, NURTEC ODT, AIRSUPRA, REXULTI, QULIPTA, BREZTRI, VRAYLAR, Veozah.
Industry payments across MO — which companies pay providers there.
